Efficacy of the HPV-16/18 AS04-Adjuvanted Vaccine Against Low-Risk HPV Types (PATRICIA Randomized Trial): An Unexpected Observation
Anne Szarewski, S Rachel Skinner, Suzanne M Garland, Barbara Romanowski, Tino F Schwarz, Dan Apter, Song-Nan Chow, Jorma Paavonen, M Rowena Del Rosario-Raymundo, Julio C Teixeira, Newton S De Carvalho, Maria Castro-Sanchez, Xavier Castellsague, Willy AJ Poppe, Philippe De Sutter, Warner Huh, Archana Chatterjee, Wiebren A Tjalma, Ronald T Ackerman, Mark Martens Show all
Journal of Infectious Diseases | OXFORD UNIV PRESS INC | Published : 2013
Awarded by GlaxoSmithKline group of companies
This work (NCT00122681) was supported by the GlaxoSmithKline group of companies, which designed the study in collaboration with investigators and coordinated collection, analysis, and interpretation of data. Investigators from the PATRICIA Study Group collected data for the trial and cared for the subjects. The authors had full access to all the trial data and had final responsibility for the decision to submit for publication.